1:40 am Pfizer provides detailed results of OPT Compare Phase 3 study of Tofacitinib 5 mg and 10 mg twice daily compared to high-dose ENBREL in adults with moderate-to-severe chronic plaque psoriasis
View todays social media effects on PFE
View the latest stocks trending across Twitter. Click to view dashboard
See who Pfizer is hiring next, click here to view
